Name
Osaühing Arvenos
Registry code
10616558
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.12.1999 (24)
Financial year
01.01-31.12
Capital
2 558.00 €
Activity
86221 - Provision of specialised medical treatment
342 224 €
38 749 €
11%
3 615 €
(estimate is approximate)
93 770 €
2
Submitted
No tax arrears
41%
37%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maike Parve 12.09.1950 (74) | 50% - 1 279.00 EUR | Board member | Direct ownership | |
| Rasmus Parve 23.03.1980 (44) | 50% - 1 279.00 EUR | Board member | Direct ownership | |
| Osaühing Casa Consulting 10509101 | - | - | - | Founder |
| 2019 01.07.2020 | 2020 29.06.2021 | 2021 04.07.2022 | 2022 27.06.2023 | 2023 25.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 342 549 € | 354 426 € | 348 145 € | 235 221 € | 342 224 € |
| Net profit (loss) for the period | 34 767 € | 28 527 € | 8 594 € | -45 769 € | 38 749 € |
| Profit Margin | 10% | 8% | 2% | -19% | 11% |
| Current Assets | 73 343 € | 97 262 € | 135 214 € | 40 843 € | 72 211 € |
| Fixed Assets | 146 161 € | 205 149 € | 46 991 € | 46 035 € | 31 277 € |
| Total Assets | 219 504 € | 302 411 € | 182 205 € | 86 878 € | 103 488 € |
| Current Liabilities | 15 948 € | 35 889 € | 27 086 € | 25 857 € | 9 718 € |
| Non Current Liabilities | 3 887 € | 38 326 € | 18 329 € | 0 € | 0 € |
| Total Liabilities | 19 835 € | 74 215 € | 45 415 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 199 669 € | 228 196 € | 136 790 € | 61 021 € | 93 770 € |
| Employees | 3 | 3 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 16 110.07 € | 15 277.56 € | 9 |
| 2023 Q4 | - | 12 861.85 € | 12 956.05 € | 9 |
| 2023 Q3 | - | 13 215.85 € | 13 356.83 € | 9 |
| 2023 Q2 | - | 10 174.21 € | 10 196 € | 9 |
| 2023 Q1 | - | 16 321.97 € | 11 455.98 € | 10 |
| 2022 Q4 | - | 8 615.37 € | 8 588.92 € | 9 |
| 2022 Q3 | - | 9 161.97 € | 9 133.66 € | 8 |
| 2022 Q2 | - | 7 217.65 € | 7 120.4 € | 8 |
| 2022 Q1 | - | 6 071.11 € | 6 144.28 € | 7 |
| 2021 Q4 | - | 32 104.33 € | 7 150.77 € | 8 |
| 2021 Q3 | - | 12 190.48 € | 12 310.79 € | 12 |
| 2021 Q2 | - | 13 771.83 € | 13 596.64 € | 12 |
| 2021 Q1 | - | 13 228.24 € | 13 371.16 € | 13 |
| 2020 Q4 | - | 13 485.17 € | 13 364.15 € | 14 |
| 2020 Q3 | - | 11 346.11 € | 11 296.31 € | 13 |
| 2020 Q2 | - | 11 966.08 € | 11 828.49 € | 14 |
| 2020 Q1 | - | 11 181.02 € | 11 123.07 € | 14 |
